Does TEMOZOLOMIDE Cause Diffuse large b-cell lymphoma refractory? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Diffuse large b-cell lymphoma refractory have been filed in association with TEMOZOLOMIDE (TEMOZOLOMIDE). This represents 0.0% of all adverse event reports for TEMOZOLOMIDE.
5
Reports of Diffuse large b-cell lymphoma refractory with TEMOZOLOMIDE
0.0%
of all TEMOZOLOMIDE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From TEMOZOLOMIDE?
Of the 5 reports.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEMOZOLOMIDE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TEMOZOLOMIDE Cause?
Disease progression (1,562)
Death (1,403)
Off label use (1,357)
Product use in unapproved indication (1,353)
Thrombocytopenia (1,300)
Drug ineffective (1,131)
Nausea (1,071)
Neutropenia (809)
Malignant neoplasm progression (779)
Fatigue (766)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which TEMOZOLOMIDE Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
TEMOZOLOMIDE vs TEMSIROLIMUS
TEMOZOLOMIDE vs TENAMFETAMINE
TEMOZOLOMIDE vs TENAPANOR
TEMOZOLOMIDE vs TENECTEPLASE
TEMOZOLOMIDE vs TENELIGLIPTIN